PP-089 A new ultra short regimen with dexlansoprazole, moxifloxacin, amoxicillin, nitazoxanide, and doxycycline (DeMAND) in eradication of Helicobacter pylori: an open-label randomized clinical trial

P.P.Basu; N.Krishnaswamy; R.Korapati; S.Tammisetti; N.J.Shah; H.Hampole; T.Pacana; C.C.Tang

首页> 外文期刊>International journal of infectious diseases : >PP-089 A new ultra short regimen with dexlansoprazole, moxifloxacin, amoxicillin, nitazoxanide, and doxycycline (DeMAND) in eradication of Helicobacter pylori: an open-label randomized clinical trial

【24h】

PP-089 A new ultra short regimen with dexlansoprazole, moxifloxacin, amoxicillin, nitazoxanide, and doxycycline (DeMAND) in eradication of Helicobacter pylori: an open-label randomized clinical trial

机译：PP-089一种新的超短疗程与右兰索拉唑，莫西沙星，阿莫西林，硝唑尼特和多西环素（DeMAND）根除幽门螺杆菌：一项开放标签的随机临床试验

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International journal of infectious diseases :》 |2010年第2期|共1页
作者
P.P.Basu; N.Krishnaswamy; R.Korapati; S.Tammisetti; N.J.Shah; H.Hampole; T.Pacana; C.C.Tang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类传染病;
关键词

相似文献

外文文献
中文文献

1. OL-015 A randomized open-label clinical trial with Levofloxacin, Omeprazole, Alinia (nitazoxanide), and Doxycycline (LOAD) versus Lansoprazole, Amoxicillin and Clarithromycin (LAC) in the treatment naive Helicobacter pylori population [J] . P.Patrick Basu, Krishna Rayapudi, Tommy Pacana, International journal of infectious diseases : . 2009,第Supplementa1期

机译：OL-015与左氧氟沙星，奥美拉唑，艾莉娅（硝唑尼特）和多西环素（LOAD）对比兰索拉唑，阿莫西林和克拉霉素（LAC）进行的未治疗的幽门螺杆菌人群随机对照试验
2. Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial [J] . Fariborz Mansour-Ghanaei, Alireza Samadi, Farahnaz Joukar, EXCLI Journal . 2019,第3期

机译：14天顺序四肢细胞疗法的疗效和耐受性：泮托拉唑，铋，阿莫西林，甲硝唑和呋喃唑酮作为一种消除幽门螺杆菌的一线治疗：随机，双盲临床试验
3. Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection [J] . Fu Wei, Song Zhiqiang, Zhou Liya, Digestive Diseases and Sciences . 2017,第6期

机译：随机临床试验：Esomeprazole，铋，左氧氟沙星和阿莫西林或头孢虫毒素作为幽门螺杆菌感染的一线根除方案
4. Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole bismuth amoxicillin metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized double-blind clinical trial [O] . Fariborz Mansour-Ghanaei, Alireza Samadi, Farahnaz Joukar, 2019

机译：十四天连续四次方案：pan托拉唑铋阿莫西林甲硝唑和/或呋喃唑酮作为根除幽门螺杆菌的一线治疗的疗效和耐受性：一项随机双盲临床试验
5. PP-089 A new ultra short regimen with dexlansoprazole, moxifloxacin, amoxicillin, nitazoxanide, and doxycycline (DeMAND) in eradication of Helicobacter pylori: an open-label randomized clinical trial [O] . Basu P.P., Krishnaswamy N., Korapati R., 2010

机译：PP-089一种新的超短疗程与右兰索拉唑，莫西沙星，阿莫西林，硝唑尼特和多西环素（DeMAND）根除幽门螺杆菌：一项开放标签的随机临床试验

PP-089 A new ultra short regimen with dexlansoprazole, moxifloxacin, amoxicillin, nitazoxanide, and doxycycline (DeMAND) in eradication of Helicobacter pylori: an open-label randomized clinical trial

著录项

相似文献

相关主题

期刊订阅